PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
03-Feb-2023 IMFINZI (DURVALUMAB) IN COMBINATION WITH GEMCITABINE AND CISPLATIN APPROVED IN GREAT BRITAIN AS A FIRST-LINE TREATMENT FOR ADULT PATIENTS WITH LOCALLY ADVANCED, UNRESECTABLE OR METASTATIC BILIARY TRACT CANCER AstraZeneca
03-Feb-2023 Tezspire approved for self-administration in the US with a new pre-filled pen AstraZeneca
03-Feb-2023 CAS and Torx Software collaborate to streamline and accelerate small molecule discovery and design Torx Software
03-Feb-2023 AC Immune to Present at the SVB Securities Global Biopharma Conference AC Immune
03-Feb-2023 OptiBiotix to showcase its progressive microbiome research at Probiota 2023 OptiBiotix
03-Feb-2023 New Phesi analysis reveals almost a fifth of investigator sites in cancer trials have recruited only one patient Phesi Inc
03-Feb-2023 IMFINZI (DURVALUMAB) IN COMBINATION WITH GEMCITABINE AND CISPLATIN APPROVED IN GREAT BRITAIN AS A FIRST-LINE TREATMENT FOR ADULT PATIENTS WITH LOCALLY ADVANCED, UNRESECTABLE OR METASTATIC BILIARY TRACT CANCER AstraZeneca
03-Feb-2023 North America Gastrointestinal Therapeutics Market Research Report 2022 - ResearchAndMarkets.com Businesswire
03-Feb-2023 Re:course AI Secures $4.3m to Reimagine Healthcare Training with AI-Powered Digital Humans Re:course AI
03-Feb-2023 Anaveon doses first patient in a Phase I/II Study of ANV419 as monotherapy or in combination with check point inhibitors in patients with advanced melanoma Anaveon
03-Feb-2023 Pharmapack Europe Awards Winners 2023 Pharmapack
03-Feb-2023 BioCardia and CellProthera Enhance Collaboration for Development of ProtheraCytes(TM) for the Treatment of Acute Myocardial Infarction in Europe and Potential Early Access for Patients BioCardia
03-Feb-2023 Vetter’s Clinical Facility Demonstrates Success with Five Client Products Now on the Market Vetter
03-Feb-2023 The World Health Organisation chooses British air purification company, MedicAir, to tackle ‘invisible threat’ in hospitals MedicAir
03-Feb-2023 Pharma industry urges halt to further rises in record revenue clawbacks ABPI
03-Feb-2023 MHRA Approves RINVOQ®▼ (upadacitinib) as First Oral Advanced Therapy to Treat Adults with Moderately to Severely Active Crohn's Disease AbbVie
03-Feb-2023 SCOTTISH BIOTECH COMPANY ANNOUNCES DRAMATIC BREAKTHROUGH IN BATTLE AGAINST COVID-19 ILC Therapeutics
03-Feb-2023 Global Needle Free Injection System Market Report 2022: Trends, Opportunities and Competitive Analysis 2021-2027 - ResearchAndMarkets.com Businesswire
03-Feb-2023 Last Chance to Register for This 2 Day Analytical Method Validation, Verification and Transfer Course: February 9-10, 2023 - ResearchAndMarkets.com Businesswire
03-Feb-2023 Global Proteomics Market Report 2022 to 2030 - Featuring Agilent Technologies, Bio-Rad Laboratories, Bruker and Siemens Among Others - ResearchAndMarkets.com Businesswire